Profile data is unavailable for this security.
About the company
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
- Revenue in USD (TTM)0.00
- Net income in USD-8.71m
- Incorporated2017
- Employees3.00
- LocationSharps Technology Inc105 Maxess Road, Ste. 124MELVILLE 11747United StatesUSA
- Phone+1 (516) 246-4000
- Websitehttps://sharpstechnology.com/
More ▼
Mergers & acquisitions
| Acquired company | STSS:NAQ since announced | Transaction value |
|---|---|---|
| Nephron Pharmaceuticals Corp-InjectEZ facility | -20.40% | -- |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arch Therapeutics Inc | 130.55k | -8.43m | 5.29m | 8.00 | -- | -- | -- | 40.51 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 5.61m | 157.00 | -- | -- | -- | 0.1142 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| SINTX Technologies Inc | 2.78m | -8.88m | 5.69m | 43.00 | -- | 0.2388 | -- | 2.05 | -389.94 | -389.94 | 74.21 | 38.86 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.8568 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Guided Therapeutics Inc | 82.00k | -3.23m | 6.07m | 4.00 | -- | -- | -- | 74.02 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Sonendo Inc | 40.19m | -57.74m | 6.13m | 216.00 | -- | 0.2499 | -- | 0.1525 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Vivos Therapeutics Inc | 13.36m | -15.64m | 6.68m | 114.00 | -- | 9.71 | -- | 0.4999 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Nexalin Technology Inc | 158.86k | -4.94m | 6.80m | 6.00 | -- | 2.92 | -- | 42.83 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| Innovative Eyewear Inc | 1.39m | -7.20m | 7.18m | 11.00 | -- | 1.39 | -- | 5.16 | -0.6074 | -0.6074 | 0.1174 | 0.2948 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Neurometrix Inc | 5.27m | -7.98m | 8.00m | 26.00 | -- | 0.4214 | -- | 1.52 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| Sharps Technology Inc | 0.00 | -8.71m | 8.11m | 3.00 | -- | 1.18 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Predictive Oncology Inc | 1.96m | -14.78m | 8.55m | 34.00 | -- | 2.09 | -- | 4.36 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Citrine Global Corp | 0.00 | -2.38m | 9.66m | 18.00 | -- | -- | -- | -- | -0.0025 | -0.0025 | 0.00 | -0.0028 | 0.00 | -- | -- | 0.00 | -173.12 | -298.98 | -- | -964.26 | -- | -- | -- | -4,814.84 | -- | -5.41 | -- | -- | -- | -- | 41.43 | -- | -5.44 | -- |
| Biomerica Inc | 5.41m | -6.35m | 10.29m | 62.00 | -- | 1.32 | -- | 1.90 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
Data as of May 28 2024. Currency figures normalised to Sharps Technology Inc's reporting currency: US Dollar USD
15.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Empery Asset Management LPas of 31 Dec 2023 | 1.24m | 7.89% |
| Walleye Capital LLCas of 31 Mar 2024 | 886.51k | 5.66% |
| HighTower Advisors LLCas of 31 Mar 2024 | 120.80k | 0.77% |
| Compass Ion Advisors LLCas of 31 Mar 2024 | 57.14k | 0.37% |
| Geode Capital Management LLCas of 31 Mar 2024 | 41.18k | 0.26% |
| XTX Markets LLCas of 31 Mar 2024 | 26.51k | 0.17% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 21.06k | 0.13% |
| Tower Research Capital LLCas of 31 Mar 2024 | 6.47k | 0.04% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 91.00 | 0.00% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 29 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
